Clinical trial · Interventional
White Tea for Prevention of Chemotherapy Induced Mucositis
Can White Tea Prevent Oral Mucositis in Patients Receiving Neoadjuvant or Adjuvant Treatment With Paclitaxel for Breast Cancer? A Randomized Trial
NCT04440930CI-TRIAL-00069317completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to determine the effectiveness of mouthwash with white tea in the prevention of paclitaxel induced oral mucositis in women with breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oral Mucositis | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Salt water with soda | Other | — | UNRESOLVED |
| White tea | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- White tea
- interventionNames
- Other: White tea
- type
- ACTIVE_COMPARATOR
- label
- Salt water with soda
- interventionNames
- Other: Salt water with soda
Primary outcomes (1)
- measure
- Incidence of oral mucositis grade 2 or higher as measured by the Revised Oral Assessment Guide.
- timeFrame
- up to nine weeks
- description
- Nine categories are included in the Revised Oral Assessment Guide tool: voice, lips, mucous, tongue, gums, teeth, saliva, denture and swallowing. Each category is described and rated according to a score of 1 (healthy) to 3 (severe problems).
Secondary outcomes (4)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Woman with breast cancer * Planned neoadjuvant or adjuvant paclitaxel treatment * Age ≥ 18 years * Understand and speak Danish * Written and orally informed consent Exclusion Criteria: \- Palliative treatment with paclitaxel
References
Publications (0)
Data not yet available
No reference posted for this study.